Skip to main content

Table 5 Tumour localisation and hippocampal dose

From: Hippocampal sparing radiotherapy for glioblastoma patients: a planning study using volumetric modulated arc therapy

 

Median (range)

p-value

3D-CRT

 

Temporal

Not temporal

 gEUD (Gy)

34.3 (26.0–48.6)

40.4 (24.3–56.1)

NS (p = 0.09)

Parietal

Not parietal

 gEUD (Gy)

40.6 (24.3–56.1)

36.0 (26.0–48.0)

NS (p = 0.40)

Frontal

Not frontal

 gEUD (Gy)

38.0 (30.8–48.6)

33.7 (24.3–56.1)

NS (p = 0.05)

VMAT

  

 Temporal

Not temporal

 gEUD (Gy)

19.5 (10.8–43.1)

31.2 (17.9–56.0)

p = 0.04

Parietal

Not parietal

 gEUD (Gy)

37.9 (25.7–56.0)

21.1 (10.8–43.1)

p < 0.01

Frontal

Not frontal

 gEUD (Gy)

22.4 (10.8–48.0)

24.1 (10.8–56.0)

NS (p = 0.86)